Skip to main content
The HFEA has launched its new Media Centre where you can find the latest news and information from us. Access it here.

PGT-M conditions

The page below lists all PGT-M conditions currently authorised and awaiting consideration by the HFEA.

When publishing genetic conditions on the authorised list, we aim to be as consistent as possible with the OMIM database. However, many conditions may have several different names and we would recommend searching the list using the OMIM number for the condition as this is less likely to change throughout time.

If a condition does not appear on the list, it does not necessarily mean the condition has specifically not been authorised, it may mean that we have never before received an application from a UK centre to perform PGT-M for this condition and it has therefore never been considered by the HFEA.

Please note that we are always processing new applications to add genetic conditions to the list from UK centres licensed to perform PGT-M. This may mean that some authorised conditions may not be displayed. If you are unsure if a condition has been authorised or not, or would like any further information please contact the PGTM team at pgtm@hfea.gov.uk.

Click here for a downloadable list: approved condition list. Please note that the website page below is updated more regularly and is therefore more accurate than the downloadable list.

Condition name Status OMIM number Documents
Axenfeld-Rieger syndrome Types 1 and 3 approved 180500, 602482
Bailey-Bloch Congenital Myopathy (BBCM) approved 255995
BAP1 tumour predisposition syndrome (BAP1-TPDS) approved 614327
Bardet-Biedl Syndrome (BBS1) approved 209900
Bardet-Biedl Syndrome 10 (BBS10) approved 615987
Bardet-Biedl Syndrome 12; BBS12 approved 615989
Bardet-Biedl Syndrome 13; BBS13 approved 615990
Bardet-Biedl Syndrome 16; BBS16 approved 615993
Bardet-Biedl Syndrome 19; BBS19 approved 615996
Bardet-Biedl Syndrome 2; BBS2 approved 615981
Bardet-Biedl Syndrome 4; BBS4 approved 615982
Bardet-Biedl Syndrome 5; BBS5 approved 615983
Bardet-Biedl Syndrome 7; BBS7 approved 615984
Bardet-Biedl Syndrome 8; BBS8 approved 615985
Bardet-Biedl Syndrome 9; BBS9 approved 615986
Bare Lymphocyte Syndrome, Type II, complementation groups A-E approved 209920
Barth Syndrome approved 302060
Bartsocas-Papas Syndrome (Popliteal Pterygium syndrome, lethal type) approved 263650
Bartter Syndrome Types 1, 2, 3, 4a & 4b (BARTS) approved 601678, 241200, 607364, 602522, 613090
Bartter Syndrome, Type 5, Antenatal, Transient; BARTS5 approved 300971